10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...tions on vaccine certificates or “passports” will be covered in an update of WHO interim guidance, as requested by the COVID-19 emergency committee.
more
Available in English, French, Spanish, Chinese, Russian and Arabic
https://apps.who.int/iris/handle/10665/337832
30 April 2020
| COVID-19: Essential health services
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
Всемирная организация здравоохранения (ВОЗ) описывает наркотическую зависимость как сильное желание потреблять психоактивные вещества, трудно контролируемое по...требление этих веществ, продолжение потребления психоактивных ве-ществ, несмотря на физические, психические и социальные проблемы, связанные с таким потреблением, постепенное повы-шение дозы, и иногда проявления абстинентного синдрома при внезапном отсутствии вещества3. Результаты исследований показывают, что наркотическая зависимость является не отсутствием воли или силы характера, а хроническим рецидивным заболеванием, имеющим психологическую и генетическую основу.
Accessed on 2019
more
Accessed 18 June 2018 | Last updated 1-Jun.-2018 (data as of 25-May-2018) | Next overall update Mid-July 2018
HIV patient monitoring and case surveillance
HIV Diagnostics
Information Note
WHO/HIV/2017.16
Procedures Manual - Medicines registration in Madagascar - 2016 version
Session Outline
•General Principles
•Essentials of mental health care and clinical practice: Assessments
•Essentials of mental health care and clinical practice: Management
•Essentials of mental health care and clinical practice: Follow-up
•Reviews
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?